Assessment of the genotoxicity of a titanium dioxide nanomaterial using a combination of in vitro and in vivo assays by Tavares, Ana et al.
Assessment of the genotoxicity of a titanium dioxide 
nanomaterial using a combination of in vitro and in vivo assays
Ana Tavares, Henriqueta Louro, Nádia Vital, Susana Antunes, João Lavinha and Maria João Silva
Instituto Nacional de Saúde Doutor Ricardo Jorge, I.P., Lisboa, Portugal
anamptavares@gmail.com
BACKGROUND
Human exposure to manufactured nanomaterials such as titanium dioxide (TiO2), often used in sunscreens
and cosmetics, has increased worldwide. Their specific properties, such as size and high surface
area/mass, render them attractive for many applications, but may also be associated to higher
toxicity in biological systems and adverse health effects.
http://www.nanogenotox.eu/
MATERIALS & METHODS
In vitro Assays In vivo Assays
Cytokinesis-block micronucleus assay results from 2000 binucleated cells
were analysed using the 2-tailed Fisher’s exact test;
 Cytokinesis block proliferation Index (Mean CBPI) was performed by one-way
ANOVA or Kruskal-Wallis test;
Mammalian Erythrocyte Micronucleus results were analysed using the Chi-
Statistical Analysis
To analyse the  potential  genotoxic  
effects  of  a well-characterized TiO2
nanomaterial,  correlating in  vitro 
and in  vivo effects.
OBJECTIVES
 Significant increase in micronucleated binucleated cells (MNBC)
frequency at concentration of 125 µg/ml (p= 0.038)
Cell cycle progression (measured by CBPI) showed no significant
decrease following exposure of lymphocytes
RESULTS
In vivo Assays
In vitro Assays
 Significant induction of DNA damage (3-fold increase) at doses 32, 64 
and 128 µg/cm2 for %DNA in tail (p= 0.005, 0.002 and 0.002, respectively)
 No dose-dependent relationship
 No chromosome breaks or loss were induced by TiO2
 No impairment of cells proliferation ability, as measured by
CBPI
No significant induction of DNA damage in liver and spleen,
measured by the % of DNA in tail, was observed after 28 days
exposure to TiO2
No significant induction of micronuclei was observed neither in mature (ERY) nor 
immature (RET) blood erythrocytes after 42h exposure to TiO2
square test;
Percentage of DNA in Tail (%DNA in tail) of BEAS-2B cells was analyzed by
one-way ANOVA (with post Hoc Tukey’s HSD test) and by Kruskal-wallis test on
liver and spleen of mice;
Regression analysis was used to try to adjust the dose-response curves to a
mathematical function.
Cytokinesis-block micronucleus assayComet Assay
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CONCLUSIONS
 Different results were obtained in vitro depending on the assay: DNA damage was observed in BEAS-2B cells, but no
significant clastogenic/aneugenic events were observed neither for BEAS-2B nor for human primary lymphocytes.
 In vivo assays (two endpoints in the same animal) revealed negative results for both endpoints tested. 
 The data  obtained for micronuclei analysis suggest a good comparability between the in vitro and in vivo  outcomes, 
pointing to the absence of genotoxic effects following exposure to this TiO2 nanomaterial at the dose levels tested.
However, somewhat different genotoxicity outcomes  concerning comet assay in vitro and in vivo may reflect tissue-
specific effects affecting, e.g., cellular uptake of the nanomaterial.
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